Consolidated Statutes and Regulations Consolidated Statutes Consolidated Regulations Annual Statutes and Regulations Annual Statutes Annual Regulations Additional information Québec Official Publisher What’s new? Information note Policy of the Minister of Justice Laws: Amendments Laws: Provisions not in force Laws: Provisions brought into force Annual Statutes: PDF versions since 1996 Regulations: Amendments Annual Regulations: PDF versions since 1996 Court Decisions

S-0.1, r. 11 - Regulation respecting the examinations and analyses that a midwife may prescribe, conduct or interpret in the practice of midwifery

Table of contents
Occurrences0
Full text
Updated to 1 January 2024
This document has official status.
chapter S-0.1, r. 11
Regulation respecting the examinations and analyses that a midwife may prescribe, conduct or interpret in the practice of midwifery
Midwives Act
(chapter S-0.1, s. 9, 2nd par.).
1. The examinations and analyses that a midwife may prescribe, conduct or interpret are
(1)  the examinations and analyses for the mother listed in Schedule I, on the conditions, if applicable, determined in the Schedule;
(2)  the examinations and analyses for the child listed in Schedule II; and
(3)  the examinations and analyses for the father listed in Schedule III, on the conditions determined in the Schedule.
For the purposes of this Regulation, a midwife may not conduct examinations and analyses in a laboratory.
O.C. 968-2008, s. 1.
2. (Omitted).
O.C. 968-2008, s. 2.
EXAMINATIONS AND ANALYSES CONCERNING THE MOTHER


Prescribe Conduct Interpret Conditions


24-hour proteinuria X X X After 20 weeks
of pregnancy

Amniocentesis X

Anatomopathology of placenta, X
membranes and cord

Bacteriological cultures of X X X
body fluids and bacterial
sensitivity test to antibiotics

Biophysical profile X

Blood and urine toxicology X X X
screening

Blood group and rhesus X X X

Complete blood count X X X

Detection of foetal cells X X X For Rh-negative
(Kleihauer) mothers
undergoing
surgery or
suffering a
trauma increasing
the risk of
foeto-maternal
transfusion where
no immunoglobulin
prophylaxy has
been received

Ferritin X X X

Foetal monitoring X X X

Folic acid X X X

Glucose tolerance test X X X

Glycemia X X X

Hemoglobin electrophoresis X X For mothers at
risk of
hemoglobinopathy

Hepatic profile (LDH, ALT, X X X
AST, GGT, conjugated and
unconjugated bilirubin)

Immune antibodies search X X X

Indirect antiglobulin test X X X

Non-stress test X X X

Obstetric ultrasound X

Papanicolaou’s stain test X X
(endocervix, ectocervix and
vagina cytology)

Pregnancy test (Beta-HCG blood) X X X

Pregnancy test (urine HCG) X X X

Renal functions studies X X X
(BUN, creatinine, protein,
albumin, uric acid, urea)

Serological examinations X X X

Serum iron + complement X X X
fixation (TIBC)

Serum markers X X

STI screening X X X

TSH level X X X

Urianalysis X X X
(physical and microscopic)

Vitamin B12 level X X X
O.C. 968-2008, Sch. I.
EXAMINATIONS AND ANALYSES CONCERNING THE CHILD


Prescribe Conduct Interpret


Bacteriological cultures of body X X X
fluids and bacterial sensitivity
test to antibiotics

Blood and urine toxicology screening X X X

Blood group and rhesus X X X

Complete blood count X X X

Conjugated and unconjugated bilirubin X X X

Direct antiglobulin test (DAT) X X X

Genetic disease (PKU) screening X X

Glycemia X X X

Non-invasive monitoring using pulse X X X
oximeter
O.C. 968-2008, Sch. II.
EXAMINATIONS AND ANALYSES CONCERNING THE FATHER
Prescribe Conduct Interpret Conditions


Blood group and rhesus X X X Test reserved for the
biological father of
the foetus of an
Rh-negative mother

Hemoglobin electrophoresis X X Test reserved for the
biological father of
the foetus of a mother
carrier of sickle
cell trait or other
hemoglo-binopathy to
evaluate foetal risk
O.C. 968-2008, Sch. III.
REFERENCES
O.C. 968-2008, 2008 G.O. 2, 5011
© Gouvernement du Québec